Microneedling with crisaborole ointment for stable vitiligo
Part of Skin clinical trials.
This trial tests whether a combination of micro-needling (tiny needles that create microscopic wounds to stimulate skin repair) and an anti-inflammatory ointment called crisaborole can help repigment white patches caused by stable vitiligo. It may be beneficial if your vitiligo has been stable and not spreading.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-segmental vitiligo (patches on both sides of the body) that has been stable, with no new spots or spreading recently.
- You are willing to participate and sign a consent form.
- You do not have any signs of active disease, such as new patches appearing or old ones growing.
- You do not tend to form keloids (thick, raised scars) when your skin is injured.
- You do not have any current skin infection.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether microneedling (tiny needles that prick the skin) combined with a chemotherapy cream (5-fluorouracil) works better than a strong steroid cream for treating vitiligo patches on a small area of the body. It's for people with limited vitiligo (covering no more than 10% of their body) who have not used other vitiligo treatments.
This trial compares two types of needle treatments (needling and microneedling) combined with light therapy to see which works better for people with vitiligo that has lasted more than a year.
This study tests whether adding a short course of steroid pills (taken by mouth in a pulse pattern) to a skin-grafting procedure helps prevent a pale ring from forming around the treated spots in people with stable vitiligo. The procedure takes healthy, pigment-making skin cells from one area and applies them to the white patches.
This trial tests a new treatment for non-segmental vitiligo that uses a special liquid made from stem cells, applied through tiny needle pricks or small injections, alongside standard light therapy. It may help restore pigment to white patches with fewer side effects than traditional treatments.
This trial tests an ointment called MH004 to see if it helps repigment white patches in people with non-segmental vitiligo (the most common type). It focuses on patches on the face and body.
This trial tests a daily pill (upadacitinib) to see if it can improve vitiligo after an initial treatment (NECS). It is for people whose vitiligo is stable and covers a limited area.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.